• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安德森-法布里病患者心脏受累早期检测中同时行 PET/MRI 的初步经验。

First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease.

机构信息

Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.

出版信息

Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1025-31. doi: 10.1007/s00259-015-3036-3. Epub 2015 Mar 26.

DOI:10.1007/s00259-015-3036-3
PMID:25808629
Abstract

PURPOSE

Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder associated with severe multiorgan dysfunction and premature death. Early diagnosis and treatment strategies play a key role in patient outcome. We investigated the potential role of hybrid PET/MR imaging in the assessment of early cardiac involvement in AFD patients.

METHODS

Thirteen AFD patients without cardiac symptoms and with normal left ventricular function underwent simultaneous cardiac PET/MR imaging after administration of (18)F-FDG. Cardiac FDG uptake was quantified by measuring the standardized uptake value in 17 myocardial segments in each subject. The coefficient of variation (COV, i.e. the standard deviation divided by the average) of the uptake of the 17 segments was calculated as an index of heterogeneity in the heart.

RESULTS

Six patients exhibited focal late gadolinium enhancement (LGE) indicating intramyocardial fibrosis, and four of these also had positive short inversion time inversion recovery (STIR) sequences. All patients with LGE and positive STIR MR images showed focal FDG uptake in the corresponding myocardial segments indicating inflammation. Of the seven patients with negative LGE and STIR images, five showed homogeneous FDG cardiac uptake and two showed heterogeneous FDG uptake. The COV was significantly greater in patients with focal FDG uptake (0.25 ± 0.02) than in those without (0.14 ± 0.07, p < 0.01).

CONCLUSION

PET/MR imaging is clinically feasible for the early detection of cardiac involvement in patients with AFD. Further studies evaluating the role of hybrid PET/MR imaging in management of the disease in larger patient populations are warranted.

摘要

目的

安德森-法布里病(AFD)是一种与多器官严重功能障碍和过早死亡相关的 X 连锁溶酶体贮积症。早期诊断和治疗策略对患者的预后起着关键作用。我们研究了杂交 PET/MR 成像在评估 AFD 患者早期心脏受累中的潜在作用。

方法

13 例无心脏症状且左心室功能正常的 AFD 患者在(18)F-FDG 给药后接受了同时进行的心脏 PET/MR 成像。通过测量每个患者 17 个心肌节段的标准化摄取值来量化心脏的 FDG 摄取。17 个节段摄取的变异系数(COV,即标准差除以平均值)作为心脏异质性的指标。

结果

6 例患者表现为局灶性晚期钆增强(LGE),提示心肌纤维化,其中 4 例也有阳性短反转时间反转恢复(STIR)序列。所有 LGE 和阳性 STIR MR 图像的患者均在相应的心肌节段显示出炎症的局灶性 FDG 摄取。在 7 例 LGE 和 STIR 图像均为阴性的患者中,5 例显示均匀的 FDG 心脏摄取,2 例显示不均匀的 FDG 摄取。局灶性 FDG 摄取患者的 COV 显著大于无局灶性 FDG 摄取患者(0.25±0.02 比 0.14±0.07,p<0.01)。

结论

PET/MR 成像临床上可用于早期检测 AFD 患者的心脏受累。需要进一步研究评估杂交 PET/MR 成像在更大患者群体中对疾病管理的作用。

相似文献

1
First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease.安德森-法布里病患者心脏受累早期检测中同时行 PET/MRI 的初步经验。
Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1025-31. doi: 10.1007/s00259-015-3036-3. Epub 2015 Mar 26.
2
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group.应用正电子发射断层扫描-磁共振成像技术评估安德森-法布里病患者不同阶段的心功能障碍:AFFINITY 研究组。
Eur Heart J Cardiovasc Imaging. 2019 Sep 1;20(9):1004-1011. doi: 10.1093/ehjci/jez039.
3
Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.携带 α-半乳糖苷酶 A 突变的女性中早期心脏受累影响左心室纵向功能:混合正电子发射断层扫描和磁共振成像及斑点追踪超声心动图的作用。
Circ Cardiovasc Imaging. 2018 Apr;11(4):e007019. doi: 10.1161/CIRCIMAGING.117.007019.
4
PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.心肌梗死后早期的 PET/MRI:对比钆延迟增强的透壁程度与 18F-FDG 摄取评估存活心肌。
Eur Heart J Cardiovasc Imaging. 2015 Jun;16(6):661-9. doi: 10.1093/ehjci/jeu317. Epub 2015 Feb 13.
5
Hybrid PET/MR imaging of the heart: feasibility and initial results.心脏 Hybrid PET/MR 成像:可行性和初步结果。
Radiology. 2013 Aug;268(2):366-73. doi: 10.1148/radiol.13130231. Epub 2013 May 7.
6
Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.心肌 FDG 摄取的异质性与心脏结节病的疾病活动。
JACC Cardiovasc Imaging. 2010 Dec;3(12):1219-28. doi: 10.1016/j.jcmg.2010.09.015.
7
Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse.心律失常性二尖瓣脱垂的正电子发射断层扫描/磁共振成像杂交术。
JAMA Cardiol. 2020 Sep 1;5(9):1000-1005. doi: 10.1001/jamacardio.2020.1555.
8
Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.通过同时进行正电子发射断层扫描/磁共振成像对缺血后心肌中18F-氟脱氧葡萄糖摄取进行前瞻性评估,作为功能转归的预后标志物。
Circ Cardiovasc Imaging. 2016 Apr;9(4):e004316. doi: 10.1161/CIRCIMAGING.115.004316.
9
Role of serial cardiac F-FDG PET-MRI in Anderson-Fabry disease: a pilot study.系列心脏F-FDG PET-MRI在安德森-法布里病中的作用:一项初步研究。
Insights Imaging. 2021 Sep 6;12(1):124. doi: 10.1186/s13244-021-01067-6.
10
Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease.Anderson - Fabry病中通过(123)I - 间碘苄胍显像测量的左心室舒张功能与心肌交感神经去神经支配之间的关系
Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):729-39. doi: 10.1007/s00259-015-3273-5. Epub 2015 Dec 7.

引用本文的文献

1
Fabry Disease: Insights into Pathophysiology and Novel Therapeutic Strategies.法布里病:对病理生理学和新型治疗策略的见解
Biomedicines. 2025 Mar 4;13(3):624. doi: 10.3390/biomedicines13030624.
2
Contemporary Multimodality Imaging for Diagnosis and Management of Fabry Cardiomyopathy.用于法布里心肌病诊断和管理的当代多模态成像
J Clin Med. 2024 Aug 14;13(16):4771. doi: 10.3390/jcm13164771.
3
Inflammation, Oxidative Stress, and Endothelial Dysfunction in the Pathogenesis of Vascular Damage: Unraveling Novel Cardiovascular Risk Factors in Fabry Disease.

本文引用的文献

1
Potential Applications of PET/MR Imaging in Cardiology.PET/MR成像在心脏病学中的潜在应用。
J Nucl Med. 2014 Jun 1;55(Supplement 2):40S-46S. doi: 10.2967/jnumed.113.129262. Epub 2014 Apr 24.
2
Continuous cardiac troponin I release in Fabry disease.法布里病中肌钙蛋白I的持续释放
PLoS One. 2014 Mar 13;9(3):e91757. doi: 10.1371/journal.pone.0091757. eCollection 2014.
3
Fibrosis: a key feature of Fabry disease with potential therapeutic implications.纤维化:法布瑞病的一个主要特征,具有潜在的治疗意义。
在血管损伤发病机制中的炎症、氧化应激和内皮功能障碍:法布里病中新型心血管风险因素的研究。
Int J Mol Sci. 2024 Jul 29;25(15):8273. doi: 10.3390/ijms25158273.
4
Cardiac Magnetic Resonance Features of Fabry Disease: From Early Diagnosis to Prognostic Stratification.法布里病的心脏磁共振特征:从早期诊断到预后分层
Rev Cardiovasc Med. 2022 May 16;23(5):177. doi: 10.31083/j.rcm2305177. eCollection 2022 May.
5
Fabry Disease Cardiomyopathy: A Review of the Role of Cardiac Imaging from Diagnosis to Treatment.法布里病心肌病:从诊断到治疗的心脏成像作用综述
Rev Cardiovasc Med. 2022 May 27;23(6):192. doi: 10.31083/j.rcm2306192. eCollection 2022 Jun.
6
Arrhythmogenesis in Fabry Disease.法布里病中的心律失常发生机制。
Curr Cardiol Rep. 2024 Jun;26(6):545-560. doi: 10.1007/s11886-024-02053-2. Epub 2024 Apr 12.
7
Advanced CMR Techniques in Anderson-Fabry Disease: State of the Art.安德森-法布里病的先进心脏磁共振成像技术:现状
Diagnostics (Basel). 2023 Aug 4;13(15):2598. doi: 10.3390/diagnostics13152598.
8
Positron Emission Tomography in Heart Failure: From Pathophysiology to Clinical Application.心力衰竭中的正电子发射断层扫描:从病理生理学到临床应用
J Cardiovasc Dev Dis. 2023 May 17;10(5):220. doi: 10.3390/jcdd10050220.
9
Impairment of sympathetic activity in Fabry disease cardiomyopathy: A further challenge for cardiac imaging.法布里病心肌病中交感神经活动受损:心脏成像面临的又一挑战。
J Nucl Cardiol. 2023 Oct;30(5):1822-1824. doi: 10.1007/s12350-023-03261-z. Epub 2023 May 4.
10
Detection of sympathetic denervation defects in Fabry disease by hybrid [C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance.应用混合 [C]间羟麻黄碱正电子发射断层扫描和心脏磁共振成像检测法布里病的交感神经去神经缺陷。
J Nucl Cardiol. 2023 Oct;30(5):1810-1821. doi: 10.1007/s12350-023-03205-7. Epub 2023 Feb 28.
Orphanet J Rare Dis. 2013 Aug 6;8:116. doi: 10.1186/1750-1172-8-116.
4
SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0.SNMMI/ASNC/SCCT心脏SPECT/CT和PET/CT指南1.0版
J Nucl Med. 2013 Aug;54(8):1485-507. doi: 10.2967/jnumed.112.105155. Epub 2013 Jun 18.
5
Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease.活动性心脏结节病:正电子发射断层扫描与磁共振成像同步用于诊断心脏疾病的首例临床经验
Circulation. 2013 Jun 4;127(22):e639-41. doi: 10.1161/CIRCULATIONAHA.112.001217.
6
The prognostic role of late gadolinium enhancement magnetic resonance imaging in patients with cardiomyopathy.晚期钆增强磁共振成像在心肌病患者中的预后作用。
Can J Cardiol. 2013 Mar;29(3):329-36. doi: 10.1016/j.cjca.2012.11.033.
7
Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects.心脏的杂交 PET/MR 成像:潜力、初步经验和未来前景。
J Nucl Med. 2013 Mar;54(3):402-15. doi: 10.2967/jnumed.112.105353. Epub 2013 Feb 12.
8
Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature.法布里病患者的酶替代疗法:最新技术和文献回顾。
Mol Genet Metab. 2012 Nov;107(3):267-75. doi: 10.1016/j.ymgme.2012.08.003. Epub 2012 Aug 11.
9
Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment.心肌水肿的心血管磁共振短反转时间反转恢复(STIR)黑血技术:视觉和半定量评估的诊断准确性。
J Cardiovasc Magn Reson. 2012 Mar 28;14(1):22. doi: 10.1186/1532-429X-14-22.
10
Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines.钆增强心血管磁共振:给药剂量与美国食品和药物管理局(FDA)指南的关系。
J Cardiovasc Magn Reson. 2012 Feb 29;14(1):18. doi: 10.1186/1532-429X-14-18.